Showing results (31-40 of 232) with videos related to
Sort By:
Pageof 24
Best Practice & Research. Clinical Haematology|December 5, 2009
Management of drug toxicities in chronic myeloid leukaemiaMichael J Mauro, Michael W DeiningerRisk Analysis : an Official Publication of the Society for Risk Analysis|April 19, 2008
Farmer knowledge and risk analysis: postrelease evaluation of herbicide-tolerant canola in Western CanadaIan J Mauro, Stéphane M McLachlanHematology. American Society of Hematology. Education Program|February 20, 2015
Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsDavid T Yeung, Michael J MauroBone Marrow Transplantation|August 28, 2003
Transplantation for chronic myelogenous leukemia: yes, no, maybe so. . . An Oregon perspectiveRichard T Maziarz, Michael J MauroBiological Cybernetics|November 8, 2019
Investigating the role of gap junctions in seizure wave propagationLaura R González-Ramírez, Ava J MauroG3 (Bethesda, Md.)|August 23, 2014
Small RNA expression from the human macrosatellite DXZ4Michael Pohlers, J Mauro Calabrese, Terry MagnusonClinical Advances in Hematology & Oncology : H&O|November 29, 2012
Clinical roundtable monograph: Emerging treatment options for TKI-resistant chronic myelogenous leukemiaJorge Cortes, Jerald Radich, Michael J MauroClinicoeconomics and Outcomes Research : CEOR|July 4, 2012
Retrospective US database analysis of drug utilization patterns, health care resource use, and costs associated with adjuvant interferon alfa-2b therapy for treatment of malignant melanoma following surgeryMichelle D Hackshaw, Arun Krishna, David J MauroCancer|October 6, 2010
Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: Definitions and clinical implicationsJavier Pinilla-Ibarz, Jorge Cortes, Michael J MauroPageof 24